A novel colony‐stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor
暂无分享,去创建一个
H. Gelderblom | H. Mei | M. A. van de Sande | J. Bovée | K. Szuhai | A. Lipplaa | M. V. D. van de Sande | Debora M Meijer
[1] R. West,et al. Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors , 2022, bioRxiv.
[2] H. Gelderblom,et al. Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches , 2022, Expert opinion on therapeutic targets.
[3] D. Antičević. Benign tumors and tumor like lesions. , 2020 .
[4] T. Nielsen,et al. Detection of CSF1 rearrangements deleting the 3′ UTR in tenosynovial giant cell tumors , 2020, Genes, chromosomes & cancer.
[5] Sakae Tanaka,et al. Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations , 2019, International journal of cancer.
[6] B. Haas,et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods , 2019, Genome Biology.
[7] M. A. van de Sande,et al. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee? , 2018, Histopathology.
[8] S. Kõks,et al. Transcriptional landscape of human endogenous retroviruses (HERVs) and other repetitive elements in psoriatic skin , 2018, Scientific Reports.
[9] N. Bannert,et al. HERVs New Role in Cancer: From Accused Perpetrators to Cheerful Protectors , 2018, Front. Microbiol..
[10] K. Kojima. Human transposable elements in Repbase: genomic footprints from fish to humans , 2018, Mobile DNA.
[11] Cong Ma,et al. SQUID: transcriptomic structural variation detection from RNA-seq , 2017, bioRxiv.
[12] M. A. O. Ignacio,et al. How to cite this article , 2016 .
[13] Patricia Rodriguez-Tomé,et al. Classification and characterization of human endogenous retroviruses; mosaic forms are common , 2016, Retrovirology.
[14] P. Picci,et al. Fusion events lead to truncation of FOS in epithelioid hemangioma of bone , 2015, Genes, chromosomes & cancer.
[15] Ke Ma,et al. Molecular Pathways: Cbl Proteins in Tumorigenesis and Antitumor Immunity—Opportunities for Cancer Treatment , 2014, Clinical Cancer Research.
[16] B. Bjerkehagen,et al. Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors , 2014, International journal of oncology.
[17] Csaba Laszlo,et al. Nucleolin Mediates MicroRNA-directed CSF-1 mRNA Deadenylation but Increases Translation of CSF-1 mRNA* , 2013, Molecular & Cellular Proteomics.
[18] Jun Wang,et al. SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data , 2013, Genome Biology.
[19] Alberto Magi,et al. Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript , 2012, Bioinform..
[20] S. Greco,et al. Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152 , 2012, Molecular Cancer.
[21] Fang Fang,et al. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution , 2011, Bioinform..
[22] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[23] Ralph Stadhouders,et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma , 2010, Nature Medicine.
[24] J. McAlpine,et al. The Multifunctional Protein Glyceraldehyde-3-Phosphate Dehydrogenase Is Both Regulated and Controls Colony-Stimulating Factor-1 Messenger RNA Stability in Ovarian Cancer , 2008, Molecular Cancer Research.
[25] Chien-Feng Li,et al. Malignant Diffuse-type Tenosynovial Giant Cell Tumors: A Series of 7 Cases Comparing With 24 Benign Lesions With Review of the Literature , 2008, The American journal of surgical pathology.
[26] F. Mertens,et al. Molecular identification of COL6A3‐CSF1 fusion transcripts in tenosynovial giant cell tumors , 2008, Genes, chromosomes & cancer.
[27] S. Dhanasekaran,et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.
[28] R. West,et al. Translocation and Expression of CSF1 in Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor, Rheumatoid Arthritis and Other Reactive Synovitides , 2007, The American journal of surgical pathology.
[29] H. Tanke,et al. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. , 2007, Cancer genetics and cytogenetics.
[30] Robert J. Marinelli,et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[31] H. Tanke,et al. COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping , 2006, Nature Protocols.
[32] M. Azodi,et al. Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. , 2005, Cancer research.
[33] S. Rowland-Jones,et al. Demystified . . . Human endogenous retroviruses , 2003, Molecular pathology : MP.
[34] D. Birnbaum,et al. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). , 2003, Blood.
[35] P. D. Dal Cin,et al. Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors , 2002, Virchows Archiv.
[36] Jan Paces,et al. HERVd: database of human endogenous retroviruses , 2002, Nucleic Acids Res..
[37] David J Griffiths,et al. Endogenous retroviruses in the human genome sequence , 2001, Genome Biology.
[38] H. Tanke,et al. Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25‐color COBRA‐FISH , 2000, Genes, chromosomes & cancer.
[39] D. Bowtell,et al. The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.
[40] T. Tsukamoto,et al. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma. , 1998, Biochemical and biophysical research communications.
[41] A. Andersson,et al. Expression of human endogenous retrovirus ERV3 (HERV-R) mRNA in normal and neoplastic tissues. , 1998, International journal of oncology.
[42] A. Wellstein,et al. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] K. Roemer,et al. Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. , 1996, Cancer research.
[44] E. Kremmer,et al. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas , 1995, Journal of virology.
[45] R. Kurth,et al. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells. , 1993, Virology.
[46] R. Hehlmann,et al. Human endogenous retroviruses. , 1988, Leukemia.